1. Home
  2. BBNX vs NPCE Comparison

BBNX vs NPCE Comparison

Compare BBNX & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beta Bionics Inc.

BBNX

Beta Bionics Inc.

HOLD

Current Price

$14.61

Market Cap

493.1M

Sector

Health Care

ML Signal

HOLD

Logo Neuropace Inc.

NPCE

Neuropace Inc.

HOLD

Current Price

$15.98

Market Cap

536.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBNX
NPCE
Founded
2015
1997
Country
United States
United States
Employees
423
N/A
Industry
Medical/Dental Instruments
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
493.1M
536.6M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
BBNX
NPCE
Price
$14.61
$15.98
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
6
Target Price
$23.80
$18.33
AVG Volume (30 Days)
780.1K
139.1K
Earning Date
04-21-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
29.03
EPS
N/A
N/A
Revenue
N/A
$99,986,000.00
Revenue This Year
$34.90
$0.90
Revenue Next Year
$34.63
$24.46
P/E Ratio
N/A
N/A
Revenue Growth
N/A
25.13
52 Week Low
$8.80
$7.56
52 Week High
$32.71
$19.60

Technical Indicators

Market Signals
Indicator
BBNX
NPCE
Relative Strength Index (RSI) 71.48 47.58
Support Level $9.34 $15.40
Resistance Level $15.53 $17.37
Average True Range (ATR) 0.96 0.80
MACD 0.27 -0.10
Stochastic Oscillator 91.73 23.53

Price Performance

Historical Comparison
BBNX
NPCE

About BBNX Beta Bionics Inc.

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.

About NPCE Neuropace Inc.

NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.

Share on Social Networks: